During the past decade, Gailey Eye Clinic conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gailey Eye Clinic" #1 sponsor was "Jaeb Center for Health Research" with 4 trials, followed by "Allergan" with 2 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored, "Paul Yates, MD, PhD" with 1 trials sponsored and "Xbrane Biopharma AB" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gailey Eye Clinic" #1 collaborator was "National Eye Institute (NEI)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "MEDARVA Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Gailey Eye Clinic" are "Macular Degeneration" (3 trials), "Diabetic Macular Edema" (1 trials), "Diabetic Retinopathy" (1 trials), "Full-thickness Macular Holes (MH)" (1 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Gailey Eye Clinic" in a lesser frequency.

Most popular intervention types in "Gailey Eye Clinic" are "Drug" (6 trials), "Device" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ranibizumab" (2 trials), "2-mg Intravitreous Aflibercept Injection" (1 trials), "Abicipar Pegol" (1 trials), "Abicipar pegol" (1 trials) and "Deferred aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gailey Eye Clinic" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Gailey Eye Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Gailey Eye Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gailey Eye Clinic, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".